Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles
NCT05980091Phase 1Suspended
- Sponsor
- ART Fertility Clinics
- Start
- Sep 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in infertility (2 arms), sponsored by ART Fertility Clinics. Primary endpoint: Livebirth rate at 41 weeks. Started Sep 2023; status: suspended.
02
Conditions
infertility
Beyond the preview
Go deeper on NCT05980091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05980091.